Advertisement
Trulieve Cannabis Corp.

Trulieve Cannabis Corp. Fundamental Analysis

TRUL.CNCNQ
HealthcareDrug Manufacturers - Specialty & Generic
$16.14
$2.010(11.07%)
Canadian Market is Open · 10:56
Advertisement

Trulieve Cannabis Corp. Fundamental Analysis

Trulieve Cannabis Corp. (TRUL.CN) shows weak financial fundamentals with a PE ratio of -26.81, profit margin of -6.99%, and ROE of -6.88%. The company generates $1.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position11.36%
PEG Ratio-0.57
Current Ratio5.26

Areas of Concern

ROE-6.88%
We analyze TRUL.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 17.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
17.9/100

We analyze TRUL.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

TRUL.CN struggles to generate sufficient returns from assets.

ROA > 10%
-2.94%

Valuation Score

Excellent

TRUL.CN trades at attractive valuation levels.

PE < 25
-26.81
PEG Ratio < 2
-0.57

Growth Score

Weak

TRUL.CN faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

TRUL.CN maintains a strong and stable balance sheet.

Debt/Equity < 1
0.54
Current Ratio > 1
5.26

Profitability Score

Weak

TRUL.CN struggles to sustain strong margins.

ROE > 15%
-687.92%
Net Margin ≥ 15%
-6.99%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is TRUL.CN Expensive or Cheap?

P/E Ratio

TRUL.CN trades at -26.81 times earnings. This suggests potential undervaluation.

-26.81

PEG Ratio

When adjusting for growth, TRUL.CN's PEG of -0.57 indicates potential undervaluation.

-0.57

Price to Book

The market values Trulieve Cannabis Corp. at 1.88 times its book value. This may indicate undervaluation.

1.88

EV/EBITDA

Enterprise value stands at 5.11 times EBITDA. This is generally considered low.

5.11

How Well Does TRUL.CN Make Money?

Net Profit Margin

For every $100 in sales, Trulieve Cannabis Corp. keeps $-6.99 as profit after all expenses.

-6.99%

Operating Margin

Core operations generate 13.57 in profit for every $100 in revenue, before interest and taxes.

13.57%

ROE

Management delivers $-6.88 in profit for every $100 of shareholder equity.

-6.88%

ROA

Trulieve Cannabis Corp. generates $-2.94 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.94%

Following the Money - Real Cash Generation

Operating Cash Flow

Trulieve Cannabis Corp. produces operating cash flow of $245.10M, showing steady but balanced cash generation.

$245.10M

Free Cash Flow

Trulieve Cannabis Corp. generates strong free cash flow of $209.27M, providing ample flexibility for dividends, buybacks, or growth.

$209.27M

FCF Per Share

Each share generates $1.23 in free cash annually.

$1.23

FCF Yield

TRUL.CN converts 12.26% of its market value into free cash.

12.26%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-26.81

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.57

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.88

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.65

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.54

vs 25 benchmark

Current Ratio

Current assets to current liabilities

5.26

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.07

vs 25 benchmark

ROA

Return on assets percentage

-0.03

vs 25 benchmark

ROCE

Return on capital employed

0.06

vs 25 benchmark

How TRUL.CN Stacks Against Its Sector Peers

MetricTRUL.CN ValueSector AveragePerformance
P/E Ratio-26.8133.74 Better (Cheaper)
ROE-6.88%404.00% Weak
Net Margin-6.99%-40219.00% (disorted) Weak
Debt/Equity0.540.81 Strong (Low Leverage)
Current Ratio5.265.53 Strong Liquidity
ROA-2.94%-281.00% (disorted) Weak

TRUL.CN outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Trulieve Cannabis Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ